Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Preferential degradation of cognitive networks differentiates Alzheimer's disease from ageing.

Chhatwal JP, Schultz AP, Johnson KA, Hedden T, Jaimes S, Benzinger TLS, Jack C Jr, Ances BM, Ringman JM, Marcus DS, Ghetti B, Farlow MR, Danek A, Levin J, Yakushev I, Laske C, Koeppe RA, Galasko DR, Xiong C, Masters CL, Schofield PR, Kinnunen KM, Salloway S, Martins RN, McDade E, Cairns NJ, Buckles VD, Morris JC, Bateman R, Sperling RA; Dominantly Inherited Alzheimer Network.

Brain. 2018 May 1;141(5):1486-1500. doi: 10.1093/brain/awy053.

2.

Neurological manifestations of autosomal dominant familial Alzheimer's disease: a comparison of the published literature with the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS).

Tang M, Ryman DC, McDade E, Jasielec MS, Buckles VD, Cairns NJ, Fagan AM, Goate A, Marcus DS, Xiong C, Allegri RF, Chhatwal JP, Danek A, Farlow MR, Fox NC, Ghetti B, Graff-Radford NR, Laske C, Martins RN, Masters CL, Mayeux RP, Ringman JM, Rossor MN, Salloway SP, Schofield PR, Morris JC, Bateman RJ; Dominantly Inherited Alzheimer Network (DIAN).

Lancet Neurol. 2016 Dec;15(13):1317-1325. doi: 10.1016/S1474-4422(16)30229-0. Epub 2016 Oct 21. Review. Erratum in: Lancet Neurol. 2017 Jan;16(1):24.

3.

Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease.

Fagan AM, Xiong C, Jasielec MS, Bateman RJ, Goate AM, Benzinger TL, Ghetti B, Martins RN, Masters CL, Mayeux R, Ringman JM, Rossor MN, Salloway S, Schofield PR, Sperling RA, Marcus D, Cairns NJ, Buckles VD, Ladenson JH, Morris JC, Holtzman DM; Dominantly Inherited Alzheimer Network.

Sci Transl Med. 2014 Mar 5;6(226):226ra30. doi: 10.1126/scitranslmed.3007901.

4.

Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease.

Benzinger TL, Blazey T, Jack CR Jr, Koeppe RA, Su Y, Xiong C, Raichle ME, Snyder AZ, Ances BM, Bateman RJ, Cairns NJ, Fagan AM, Goate A, Marcus DS, Aisen PS, Christensen JJ, Ercole L, Hornbeck RC, Farrar AM, Aldea P, Jasielec MS, Owen CJ, Xie X, Mayeux R, Brickman A, McDade E, Klunk W, Mathis CA, Ringman J, Thompson PM, Ghetti B, Saykin AJ, Sperling RA, Johnson KA, Salloway S, Correia S, Schofield PR, Masters CL, Rowe C, Villemagne VL, Martins R, Ourselin S, Rossor MN, Fox NC, Cash DM, Weiner MW, Holtzman DM, Buckles VD, Moulder K, Morris JC.

Proc Natl Acad Sci U S A. 2013 Nov 19;110(47):E4502-9. doi: 10.1073/pnas.1317918110. Epub 2013 Nov 5.

5.

Dominantly Inherited Alzheimer Network: facilitating research and clinical trials.

Moulder KL, Snider BJ, Mills SL, Buckles VD, Santacruz AM, Bateman RJ, Morris JC.

Alzheimers Res Ther. 2013 Oct 17;5(5):48. doi: 10.1186/alzrt213. eCollection 2013. Review.

6.

Preclinical trials in autosomal dominant AD: implementation of the DIAN-TU trial.

Mills SM, Mallmann J, Santacruz AM, Fuqua A, Carril M, Aisen PS, Althage MC, Belyew S, Benzinger TL, Brooks WS, Buckles VD, Cairns NJ, Clifford D, Danek A, Fagan AM, Farlow M, Fox N, Ghetti B, Goate AM, Heinrichs D, Hornbeck R, Jack C, Jucker M, Klunk WE, Marcus DS, Martins RN, Masters CM, Mayeux R, McDade E, Morris JC, Oliver A, Ringman JM, Rossor MN, Salloway S, Schofield PR, Snider J, Snyder P, Sperling RA, Stewart C, Thomas RG, Xiong C, Bateman RJ.

Rev Neurol (Paris). 2013 Oct;169(10):737-43. doi: 10.1016/j.neurol.2013.07.017. Epub 2013 Sep 6. Review.

7.

Impaired default network functional connectivity in autosomal dominant Alzheimer disease.

Chhatwal JP, Schultz AP, Johnson K, Benzinger TL, Jack C Jr, Ances BM, Sullivan CA, Salloway SP, Ringman JM, Koeppe RA, Marcus DS, Thompson P, Saykin AJ, Correia S, Schofield PR, Rowe CC, Fox NC, Brickman AM, Mayeux R, McDade E, Bateman R, Fagan AM, Goate AM, Xiong C, Buckles VD, Morris JC, Sperling RA.

Neurology. 2013 Aug 20;81(8):736-44. doi: 10.1212/WNL.0b013e3182a1aafe. Epub 2013 Jul 24.

8.

Preclinical Alzheimer disease and risk of falls.

Stark SL, Roe CM, Grant EA, Hollingsworth H, Benzinger TL, Fagan AM, Buckles VD, Morris JC.

Neurology. 2013 Jul 30;81(5):437-43. doi: 10.1212/WNL.0b013e31829d8599. Epub 2013 Jun 26.

9.

"Will I get Alzheimer disease?" when cognitively normal patients ask to be tested for Alzheimer disease.

Snider BJ, Buckles VD.

Continuum (Minneap Minn). 2013 Apr;19(2 Dementia):470-4. doi: 10.1212/01.CON.0000429171.50686.07.

PMID:
23558490
10.

Clinicopathologic study of Alzheimer's disease: Alzheimer mimics.

Shim YS, Roe CM, Buckles VD, Morris JC.

J Alzheimers Dis. 2013;35(4):799-811. doi: 10.3233/JAD-121594.

11.

Developing an international network for Alzheimer research: The Dominantly Inherited Alzheimer Network.

Morris JC, Aisen PS, Bateman RJ, Benzinger TL, Cairns NJ, Fagan AM, Ghetti B, Goate AM, Holtzman DM, Klunk WE, McDade E, Marcus DS, Martins RN, Masters CL, Mayeux R, Oliver A, Quaid K, Ringman JM, Rossor MN, Salloway S, Schofield PR, Selsor NJ, Sperling RA, Weiner MW, Xiong C, Moulder KL, Buckles VD.

Clin Investig (Lond). 2012 Oct 1;2(10):975-984.

12.

Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease.

Price JL, McKeel DW Jr, Buckles VD, Roe CM, Xiong C, Grundman M, Hansen LA, Petersen RC, Parisi JE, Dickson DW, Smith CD, Davis DG, Schmitt FA, Markesbery WR, Kaye J, Kurlan R, Hulette C, Kurland BF, Higdon R, Kukull W, Morris JC.

Neurobiol Aging. 2009 Jul;30(7):1026-36. doi: 10.1016/j.neurobiolaging.2009.04.002. Epub 2009 Apr 18.

13.

Driving and dementia of the Alzheimer type: beliefs and cessation strategies among stakeholders.

Perkinson MA, Berg-Weger ML, Carr DB, Meuser TM, Palmer JL, Buckles VD, Powlishta KK, Foley DJ, Morris JC.

Gerontologist. 2005 Oct;45(5):676-85.

PMID:
16199403
14.

Understanding of informed consent by demented individuals.

Buckles VD, Powlishta KK, Palmer JL, Coats M, Hosto T, Buckley A, Morris JC.

Neurology. 2003 Dec 23;61(12):1662-6.

PMID:
14694026
15.

Accuracy of collateral source reports in very mild to mild dementia of the Alzheimer type.

Cacchione PZ, Powlishta KK, Grant EA, Buckles VD, Morris JC.

J Am Geriatr Soc. 2003 Jun;51(6):819-23.

PMID:
12757569
16.

Motor dysfunction in mildly demented AD individuals without extrapyramidal signs.

Goldman WP, Baty JD, Buckles VD, Sahrmann S, Morris JC.

Neurology. 1999 Sep 22;53(5):956-62.

PMID:
10496252
17.

Cognitive and motor functioning in Parkinson disease: subjects with and without questionable dementia.

Goldman WP, Baty JD, Buckles VD, Sahrmann S, Morris JC.

Arch Neurol. 1998 May;55(5):674-80.

PMID:
9605724

Supplemental Content

Loading ...
Support Center